This document outlines our collective vision, mission, and values while reaffirming SAHPRA’s commitment to safeguarding the health and well-being of all South Africans....
Government Gazette for Class A medical devices and in vitro diagnostic exemption from section of Section 22C(1) of the medicines and related substance Act 101 of 1965....
Policy Position of SAHPRA on Enabling Local Manufacture
SAHPRA as an organ of state and a public entity is required to align itself with the national imperatives to support the national response in public health emergencies through supporting local manufacturers of health products.
...
SAHPRA's Annual Report allows for transparency, accountability, as well as a comprehensive view of the entity’s performance and strategic direction....
This Annual Performance Plan (APP) for the 2024/25 financial year that has been developed by SAHPRA, represents the planned actions of the Board of SAHPRA to ensure that through their considered and responsible actions, they can, together with the staff at the Authority, assure and...
AUDA-NEPAD has published its 2023 Highlights Edition on African Medicines Regulatory Harmonization (AMRH) featuring articles on: Harmony in healthcare 2023 highlights of the Good Manufacturing Practice Technical Committee Evaluation of Medicinal Products Technical Committee virtual meeting Plans for the College for African Regulatory Science Professionals ...
SAHPRA has launched an Online Medicines Directory. Please visit: www.medsinfo.sahpra.org.za The Online Medicines Directory has been launched for Schedule 0-2. The job is to increase awareness and use of the directory amongst consumers, patients and healthcare providers. This toolkit provides Market Authorisation Holders (MAH) and SAHPRA...